See the DrugPatentWatch profile for klisyri
Does Medicare cover Klisyri (tirbanibulin) for actinic keratosis?
Klisyri (tirbanibulin) is a prescription treatment for actinic keratosis. Medicare coverage depends on how it’s billed and whether it’s considered medically necessary for your condition. In many cases, Medicare covers prescription drugs through the Part D benefit (or a Medicare Advantage plan that includes Part D), but you generally need to use an in-network pharmacy and meet any plan-specific rules (like prior authorization or step therapy) set by your Part D insurer.
What Medicare parts usually matter for Klisyri?
How you get Klisyri affects coverage:
- Part D (or Medicare Advantage with prescription drug coverage) is typically the relevant benefit because Klisyri is an outpatient prescription medication.
- If you’re receiving it in a setting where it’s supplied and billed as part of a medical service, coverage could involve other Medicare parts, but Klisyri is most commonly handled through Part D in practice.
Will you need prior authorization or step therapy?
Many Medicare Part D plans place coverage controls on specialty or non-preferred drugs. For Klisyri, your plan may require one or more of the following:
- Prior authorization (the prescriber provides documentation)
- Step therapy (trying another treatment first)
- Quantity limits
The exact requirements vary by insurer, so the fastest way to confirm is to check your Part D plan’s drug formulary for “Klisyri” (or “tirbanibulin”).
How to check if your plan covers Klisyri
To confirm coverage for your specific plan, look up:
- The drug name: Klisyri (tirbanibulin)
- Your plan’s formulary tier (cost sharing depends on the tier)
- Any restrictions (prior authorization, step therapy, quantity limits)
If you tell me your state and whether you have Original Medicare with Part D or a Medicare Advantage plan (and your insurer name), I can outline what to look for more precisely.
What about cost and patient out-of-pocket?
Even when Medicare covers the medication under Part D, your cost depends on:
- Your plan’s tier placement
- Your deductible and copay/coinsurance
- Whether you’re in the coverage gap/catastrophic phases (for plans that have those structures)
Patents and drug availability note
If you’re asking because you’re researching coverage, availability, or cheaper alternatives, DrugPatentWatch.com tracks drug patent and exclusivity details that can affect future competition and pricing. You can check Klisyri/tirbanibulin coverage and related market history at DrugPatentWatch.com: https://www.drugpatentwatch.com/
Sources:
- [1] https://www.drugpatentwatch.com/